Cerevel Therapeutics Holdings Inc (DELISTED) (CERE:DL)
44.97
USD |
NASDAQ |
Jul 31, 16:00
Cerevel Therapeutics Holdings Enterprise Value: 7.683B for Aug. 1, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| AbbVie, Inc. | 456.92B |
| Amgen, Inc. | 219.84B |
| Biogen, Inc. | 27.56B |
| Gilead Sciences, Inc. | 166.39B |
| Eli Lilly & Co. | 978.58B |
Enterprise Value Related Metrics
| Earnings Yield | -6.07% |